Milestones in the development of modern Parkinson therapy
Birkmayer, W.
Journal of Neural Transmission. Supplementum 25: 1-3
1987
ISSN/ISBN: 0303-6995 PMID: 3123596 Document Number: 299994
Document emailed within 1 workday
Related Documents
Ransmayr, G.; Jeschow, M. 1995: Future aspects of modern Parkinson therapy Wiener Medizinische Wochenschrift 145(13): 299-301Pavoncello, S.; Di Bianco, V.; Di Castro, A.; Caviglia, A.; Cellitti, M. 1980: Neurological aspects and modern trends in therapy of Parkinson's disease La Clinica Terapeutica 92(4): 433-438
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Tunell, R. 1993: Neonatal respiratory insufficiency. Milestones in therapeutic development Lakartidningen 90(45): 3937-3938
Gupta, S.K.; Shrestha, A.; Minhas, V. 2014: Milestones in contraceptive vaccines development and hurdles in their application Human Vaccines and Immunotherapeutics 10(4): 911-925
Oberbaum, M.; Lysy, J.; Gropp, C. 2011: From Nebuchadnezzar to the randomized controlled trial--milestones in the development of clinical research Harefuah 150(8): 668-671; 686
Majewska, R.; Mrozek-Budzyn, D.; Kieltyka, A.; Augustyniak, M. 2013: Usefulness of maternal assessment of children development based on reported age of achieved milestones Przeglad Epidemiologiczny 67(3): 487-90 585-7
Hagmann, P. 1972: Milestones in the development of language in infancy. a prospective examination of 65 children including sets of twins Helvetica Paediatrica Acta 21(1): 71-84
Benki-Nugent, S.; Eshelman, C.; Wamalwa, D.; Langat, A.; Tapia, K.; Okinyi, H.M.; John-Stewart, G. 2015: Correlates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy Pediatric Infectious Disease Journal 34(1): 55-61
Ludin, H.P. 1999: Modern therapeutic possibilities in Parkinson disease Schweizerische Medizinische Wochenschrift 129(19): 741-747
Rygnestad, T. 1992: Development of physostigmine from a poisonous plant to an antidote. one of the most important drugs in the development of modern medicine? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(10): 1300-1303
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Guillard, A. 1989: Development of Parkinson's disease La Revue du Praticien 39(8): 653-657
Johnston, T.H.; Brotchie, J.M. 2004: Drugs in development for Parkinson's disease Current Opinion in Investigational Drugs 5(7): 720-726
Gofferje, H. 1976: Modern infusion therapy. 4. Disorders of magnesium balance. Pathophysiology, diagnosis and therapy Die Medizinische Welt 27(27): 1344-1348
Johnston, T.H.; Brotchie, J.M. 2006: Drugs in development for Parkinson's disease: an update Current Opinion in Investigational Drugs 7(1): 25-32
Korczyn, A.D. 2003: Dopaminergic drugs in development for Parkinson's disease Advances in Neurology 91: 267-271
Kaeser, H.E. 1981: Therapy of Parkinson Schweizerische Rundschau für Medizin Praxis 70(50): 2247-2249
Clarenbach, P.; Fröscher, W. 1986: Therapy of Parkinson syndrome Fortschritte der Medizin 104(44): 857-861
Umbach, W. 1970: Classification and therapy of the Parkinson syndrome Deutsche Medizinische Wochenschrift 95(1): 44-45